Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely
Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade the company's valuation. Learn more on BHC stock here.
Bausch + Lomb considers sale: FT
Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a market cap of $6.27 billion on Monday.
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
Bausch + Lomb stock surged Monday — briefly breaking out — on a report the company is working with advisors to explore a potential sale.
Bausch + Lomb’s stock soars 14% on report company is considering selling itself
Eye-care company is working with Goldman Sachs on a deal that would extricate it from its indebted parent, the Financial Times reported.
Bausch + Lomb reportedly exploring sale to handle Bausch Health spinoff
Bausch + Lomb (BLCO) stock will be in focus as company is exploring a sale to address concerns raised over its separation from Bausch Health (BHC). Read mroe here.
Bausch + Lomb Stock Jumps Amid Reports Of A Sale
Key Takeaways Bausch + Lomb is discussing a possible sale that would separate it from its parent company, Bausch Health Cos.Bausch Health is saddled with debt of $21 billion, nearly $10 billion of which is set to mature in 2027.
Bausch + Lomb explores sale amid parent company's debt woes - report
Bausch + Lomb (NYSE:BLCO) is exploring a potential sale as part of an effort to resolve issues related to its separation from parent company Bausch Health, which is burdened with significant debt, as per a Financial
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a ...
Bausch & Lomb Sues Competition Over Copycat Formulation and 'Confusingly Similar' Product Name
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just filed cases in state and federal courts.
The Financial Times5d
Private equity suitors line up for Bausch + Lomb eyecare auction
Bausch + Lomb is projected to generate nearly $860mn in adjusted earnings before interest, taxation, depreciation and ...
Private Equity Interest Signals Upside for Bausch + Lomb: A Buy Rating Justified
In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...
Plastics News6d
Kickstart: Focusing on a possible big deal in eye care
Consumer medical giant Bausch + Lomb may be preparing to sell off its eye care business, which would include contact lens ...
Morningstar1y
Health Care Climbs Amid Deal Intrigue - Health Care Roundup
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Needham Remains a Hold on Bausch + Lomb Corporation (BLCO)
Needham analyst David Saxon maintained a Hold rating on Bausch + Lomb Corporation (BLCO – Research Report) today. The company’s ...